Number Of Pages 1 Double Spaced

Ha19 W7r1number Of Pages 1 Double Spacednumber Of

Manage Discussion Entry Breast cancer is the second leading cause of death among women, however early detection and prevention has increased the 5-year survival of breast cancer patients above 80% (Sun et al., 2017). Based on the patient’s presentation, the two questions I would ask her, are: “When did you first notice the lump and have you noticed the lump getting bigger?” and, “Do you have any nipple discharge, if so, how much and what does it look like? And do you have nipple pain?” These are pertinent questions to ask.

I would want to know when the lump developed because that could give you an idea of how long she’s had the lump, and if it’s growing. I would want to ask her about nipple discharge and nipple pain as well. One article I read, discussed breast cancer symptoms and showed that nearly 20% of breast cancer patients experienced other symptoms than a breast lump such as nipple discharge and pain, and those patients delayed seeking help (Koo et al., 2011). Two risk factors I would assess the patient for are a family history of breast cancer as well as a personal history of any breast abnormalities such as lesions or other breast conditions. Nearly 25% of all breast cancers are related to family history, and women with a mother or sister with a diagnosis of breast cancer double their risk of breast cancer (Sun et al., 2017).

It’s also important to ask about the patient’s history of breast conditions or abnormalities, as this information can determine if she’s at an increased risk for breast cancer as well. Identifying personal and family history is crucial in risk assessment because genetics play a significant role in breast cancer development. Women with BRCA1 and BRCA2 gene mutations are at a markedly higher risk, and assessing for symptoms and risk factors can lead to earlier detection and improved outcomes (Koo et al., 2017).

Paper For Above instruction

Breast cancer remains a major global health concern, ranking as the second leading cause of cancer-related deaths among women worldwide. Despite its prevalence, advances in early detection and preventive strategies have markedly improved survival rates, with the five-year survival exceeding 80% in many cases (Sun et al., 2017). The integration of these medical advancements underscores the importance of timely diagnosis and targeted screening approaches, especially considering the variable presentation of symptoms among patients.

When evaluating a patient presenting with potential breast cancer symptoms, it is essential to formulate precise and relevant questions that can guide further diagnostic assessment. For instance, inquiring about the onset and progression of the breast lump provides insights into the duration and possible growth pattern of the lesion. The question, “When did you first notice the lump and have you noticed the lump getting bigger?” helps determine whether the lesion has changed over time, which is an important indicator of malignancy. Rapid or recent development of a lump can be a red flag, warranting prompt diagnostic investigation (Koo et al., 2017).

Another critical aspect of assessment involves understanding the characteristics of any nipple discharge. Patients may report different types and quantities of discharge, with bloody or spontaneous discharges raising higher suspicion for malignancy. As such, asking, “Do you have any nipple discharge, if so, how much and what does it look like?” is vital in screening for symptoms associated with breast cancer. Additionally, nipple pain, which is less common but still significant, warrants exploration to differentiate benign conditions from potential malignancies. For example, a patient reporting persistent nipple pain alongside other symptoms might be experiencing a more advanced or invasive process (Koo et al., 2017).

In addition to symptom-focused questions, a thorough risk assessment should include family history and personal history of breast abnormalities. Research indicates that approximately 25% of all breast cancers are linked to genetic predispositions, with women having a first-degree relative diagnosed with breast cancer experiencing a doubled risk of developing the disease (Sun et al., 2017). Such information emphasizes the importance of genetic counseling and screening for high-risk individuals, especially those with known mutations in BRCA1 or BRCA2.

Personal history variables, such as previous breast lesions, atypical hyperplasia, or benign tumors, also influence risk stratification. Women with prior breast conditions are more prone to developing malignancies, and regular screening and vigilant follow-up can aid early detection (Koo et al., 2017). Therefore, comprehensive history-taking is a cornerstone of breast cancer risk assessment and management, guiding decisions about surveillance protocols and preventative measures.

In sum, a nuanced patient interview focusing on symptom history and risk factors is vital in early breast cancer detection. Combining detailed history-taking with risk assessment tools and imaging modalities enables healthcare providers to identify at-risk women promptly. Early diagnosis not only improves prognosis but also facilitates less invasive treatment options, ultimately reducing mortality rates associated with breast cancer (Sun et al., 2017). Continuous research and education are essential to enhance screening strategies and address disparities in access to care, especially in underserved populations.

References

• Koo, M. M., von Wagner, C., Abel, G. A., McPhail, S., Rubin, G. P., & Lyratzopoulos, G. (2017). Typical and atypical presenting symptoms of breast cancer and their associations with diagnostic intervals: Evidence from a national audit of cancer diagnosis. Cancer Epidemiology, 48, 137-144. https://doi.org/10.1016/j.canep.2017.05.014
• Sun, Y. S., Zhao, Z., Yang, Z. N., Xu, F., Lu, H. J., Zhu, Z. Y., Shi, W., Jiang, J., Yao, P. P., & Zhu, H. P. (2017). Risk factors and preventions of breast cancer. International Journal of Biological Sciences, 13(11), 1476-1489. https://doi.org/10.7150/ijbs.21635
• American Cancer Society. (2020). Breast Cancer Facts & Figures 2019-2020. https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/br east-cancer-fact-figures/ACS-BCFF-2019-2020.pdf
• World Health Organization. (2018). Breast cancer: Prevention and control. https://www.who.int/cancer/prevention/diagnosis-screening/breast-cancer/en/
• Fischbach, F., & Dunning, T. (2018). Nipple Discharge and Breast Cancer: Diagnostic Approach. Journal of Clinical Oncology, 36(15), 1456-1463. https://doi.org/10.1200/JCO.2018.78.9540
• Smitten, A., et al. (2020). Genetic Counseling for Women at Increased Risk of Breast Cancer. Genetics in Medicine, 22(10), 1530-1537. https://doi.org/10.1038/s41436-020-0870-9
• National Comprehensive Cancer Network. (2021). NCCN Clinical Practice Guidelines in Oncology: Breast Cancer. https://www.nccn.org/professionals/physician_gls/pdf/breast.pdf
• Chen, Y., et al. (2019). Advances in Breast Cancer Screening and Prevention. Current Oncology Reports, 21(8), 70. https://doi.org/10.1007/s11912-019-0849-y
• Harbeck, N., et al. (2019). Management of breast cancer risk factors and screening. European Journal of Cancer, 120, 86-96. https://doi.org/10.1016/j.ejca.2019.05.014
• Ginsburg, O., et al. (2017). Breast cancer in low- and middle-income countries: Needs for comprehensive strategies. The Oncologist, 22(8), 944-952. https://doi.org/10.1634/theoncologist.2016-0194